Articles Tagged with TVM Lawsuits

Transvaginal mesh is a surgical implant designed to treat women with various conditions, including pelvic organ prolapse (POP).  This medical product was marketed as a minimally invasive means of treating these conditions. But after implantation, many women experienced painful side effects such as tearing of tissue, abrasion of vaginal tissue, and many other painful conditions for which they were not warned by Boston scientific, – the maker of many transvaginal mesh  (TVM) implants.

Surgical mesh is nothing new. It had been used to treat heart patients for many years, an even to treat various reproductive disorders in women. But transvaginal mesh was marketed as a new and effective treatment. The company managed to get it passed U.S. Food and Drug Administration (FDA) review, despite a real question as to whether adequate safety testing was performed and whether manufacturers properly notified FDA of any complications they knew or should have known about. Continue reading

According to recent news from the Legal Reader, Johnson & Johnson, a major pharmaceuticals firm and medical device manufacturer, has agreed to settle as many as 3,000 of the products liability lawsuits it is now facing related to its transvaginal mesh implant device.

The reported amount of the settlement is $120 million, and it involves claims that its transvaginal mesh products caused pelvic erosion, extreme pain and discomfort, and internal organ damage as a result of manufacturing and design defects, as well as failure to adequately warn potential victims. While many lawsuits are still ongoing, somewhere between 2,000 and 3,000 of the claims will be dismissed as part of this settlement. Continue reading

The United States Food and Drug Administration (FDA) has recently issued a press release dealing with new changes to regulations regarding the use of transvaginal mesh (TVM) implants.

Surgical mesh has been around for decades. In the 1950s, surgeons used the material to repair hernias. Two decades later, surgeons began experimenting with the use of surgical mesh to treat a serious medical condition in women known as pelvic organ prolapse (POP).   However, at that time, surgeons would make an incision in the patient’s abdomen to implant the mesh, and this led to a longer and more painful recovery than many patients would have liked. Continue reading